日韩区一区二区三区四|交换国产精品视频一区|国产口爆吞精在线观视频|午夜无码大尺度福利视频|二区亚洲国产精品一区久久|精品国产一级二级三级在线|欧美日韩精品久久久免费观看|亚洲高清一区二区三区高清不卡

position: EnglishChannel  > Policy> Setting Ethical Guardrails for R&D

Setting Ethical Guardrails for R&D

Source: Science and Technology Daily | 2023-10-10 16:09:50 | Author: Li Lin Xu

By?LI?Linxu

In its latest efforts to set ethical guardrails for science and technology, China has unveiled a range of trial measures for the ethical reviews of R&D activities.

The document, jointly released by 10 government bodies, including the Ministry of Science and Technology (MOST), the Ministry of Education, and the National Health Commission, will take effect on December 1, 2023.

It puts forward a series of comprehensive and generic measures for the ethical reviews of R&D activities in various sectors, as well as unified requirements for the basic procedures, standards and conditions of ethical reviews, said an official from MOST.

With a total of 56 measures, the document is expected to lay an institutional basis for relevant authorities and innovation entities to conduct such reviews.


Researchers conduct biospecimen medical research in a lab. (PHOTO: VCG)

R&D activities involving human participants, including tests, surveys and observations using human beings as research subjects, as well as those activities using human biological samples and personal information data, are subject to ethical reviews in accordance with these measures.

R&D activities involving experimental animals shall also carry out such ethical reviews.

For those activities that are not directly involved with human participants or experimental animals, but may pose ethical risks or challenges in life and health, ecological environment, public order, and other fields, the ethical reviews are also required.

Universities, R&D institutes, healthcare and medical institutions, and enterprises are responsibility entities for the ethical review of their own R&D activities.

For those entities engaged in life sciences, medical science, artificial intelligence, and other R&D activities that involve ethically sensitive areas, an ethical review committee shall be established.

For international cooperative R&D activities that are subject to ethical reviews, they should pass the required ethical reviews of all parties.

A list will be established for emerging R&D activities that may pose higher ethical risks or challenges, and expert review procedures shall be initiated in such reviews.

This list will be dynamically adjusted as per needs and then released by MOST.

Editor:李林旭

抱歉,您使用的瀏覽器版本過(guò)低或開(kāi)啟了瀏覽器兼容模式,這會(huì)影響您正常瀏覽本網(wǎng)頁(yè)

您可以進(jìn)行以下操作:

1.將瀏覽器切換回極速模式

2.點(diǎn)擊下面圖標(biāo)升級(jí)或更換您的瀏覽器

3.暫不升級(jí),繼續(xù)瀏覽

繼續(xù)瀏覽
衡东县| 石棉县| 米泉市| 新巴尔虎右旗| 定西市| 遂平县| 永仁县| 乐东| 岱山县| 福州市| 洪洞县| 裕民县| 汶上县| 余干县| 临武县| 新建县| 大埔县| 图木舒克市| 小金县| 通河县| 高邮市| 儋州市| 江口县| 山阳县| 虎林市| 永吉县| 玉环县| 祥云县| 历史| 邯郸市| 格尔木市| 娄底市| 五华县| 南溪县| 杭州市| 广安市| 公主岭市| 海林市| 长沙县| 马尔康县| 锡林郭勒盟|